Literature DB >> 1501573

Serum TNF alpha inhibitor in mouse typhoid.

P Mastroeni1, B Villarreal, R Demarco de Hormaeche, C E Hormaeche.   

Abstract

Administration of anti-TNF alpha antiserum enhanced a sublethal infection with salmonellae of moderate virulence (Salmonella typhimurium M525) in innately susceptible (Ity(s)) BALB/c mice, indicating that TNF alpha is important in the early response which suppresses bacterial growth in the reticuloendothelial system (RES). However, only transient low levels of TNF alpha were detectable on day 3 in sera from some, but not all, sublethally infected mice. Conversely, on day 4 of the same infection, clear TNF alpha inhibitory activity was detected in some sera. Neither TNF alpha or any inhibitory activity were detected in sera of lethally infected BALB/c mice undergoing an acute, overwhelming Salmonella infection. In contrast, TNF alpha inhibitory activity, but not TNF alpha, was detected in sera of mice showing a cachectic syndrome induced by persistent high bacterial numbers following intravenous inoculation of a very high dose (2 x 10(7)) of the attenuated aro- S. typhimurium SL3261 strain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1501573     DOI: 10.1016/0882-4010(92)90097-8

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  4 in total

Review 1.  A dynamic view of the spread and intracellular distribution of Salmonella enterica.

Authors:  Pietro Mastroeni; Andrew Grant; Olivier Restif; Duncan Maskell
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

2.  Systemic infection of mice by wild-type but not Spv- Salmonella typhimurium is enhanced by neutralization of gamma interferon and tumor necrosis factor alpha.

Authors:  P A Gulig; T J Doyle; M J Clare-Salzler; R L Maiese; H Matsui
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

3.  Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections.

Authors:  P Mastroeni; J N Skepper; C E Hormaeche
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

4.  Virulent Salmonella enterica infections can be exacerbated by concomitant infection of the host with a live attenuated S. enterica vaccine via Toll-like receptor 4-dependent interleukin-10 production with the involvement of both TRIF and MyD88.

Authors:  Gemma L Foster; Tom A Barr; Andrew J Grant; Trevelyan J McKinley; Clare E Bryant; Andrew MacDonald; David Gray; Masahiro Yamamoto; Shizuo Akira; Duncan J Maskell; Pietro Mastroeni
Journal:  Immunology       Date:  2008-02-01       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.